Immune Checkpoint Inhibition and the Risk of Radionecrosis in Patients Treated with SRS for Brain Metastases

被引：0
|
作者：
Kowalski, E. S. [1 ]
Remick, J. [1 ]
Khairnar, R. [2 ]
Morse, E. [3 ]
Poirier, Y. [1 ]
Lamichhane, N. [1 ]
Becker, S. J. [1 ]
Mishra, M. V. [1 ]
机构：
[1] Univ Maryland, Sch Med, Dept Radiat Oncol, Baltimore, MD 21201 USA
[2] Univ Maryland, Sch Pharm, Dept Pharmaceut Hlth Serv Res, Baltimore, MD 21201 USA
[3] Univ Maryland, Sch Med, Baltimore, MD 21201 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2019年 / 105卷 / 01期
关键词：
D O I：
10.1016/j.ijrobp.2019.06.2219
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2253
引用
收藏
页码：E113 / E113
页数：1
相关论文
共 50 条
  • [1] Radionecrosis (RN) in patients with brain metastases treated with stereotactic radiosurgery (SRS) and immunotherapy
    Andring, Lauren
    Squires, Bryan
    Seymour, Zachary
    Fahim, Daniel
    Jacob, Jeffrey
    Ye, Hong
    Marvin, Kimberly
    Grills, Inga
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2023, 133 (02) : 186 - 193
  • [2] Radionecrosis (RN) in Patients with Brain Metastases Treated with Stereotactic Radiosurgery (SRS) and Immunotherapy
    Foster, L. M.
    Squires, B. S.
    Ye, H.
    Marvin, K.
    Seymour, Z. A.
    Grills, I. S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E75 - E76
  • [3] Immune checkpoint inhibition in patients treated with stereotactic radiation for brain metastases
    Kowalski, Emily S.
    Remick, Jill S.
    Sun, Kai
    Alexander, Gregory S.
    Khairnar, Rahul
    Morse, Emily
    Cherng, Hua-Ren
    Berg, Lars J.
    Poirier, Yannick
    Lamichhane, Narottam
    Becker, Stewart
    Chen, Shifeng
    Molitoris, Jason K.
    Kwok, Young
    Regine, William F.
    Mishra, Mark V.
    RADIATION ONCOLOGY, 2020, 15 (01)
  • [4] Immune checkpoint inhibition in patients treated with stereotactic radiation for brain metastases
    Emily S. Kowalski
    Jill S. Remick
    Kai Sun
    Gregory S. Alexander
    Rahul Khairnar
    Emily Morse
    Hua-Ren Cherng
    Lars J. Berg
    Yannick Poirier
    Narottam Lamichhane
    Stewart Becker
    Shifeng Chen
    Jason K. Molitoris
    Young Kwok
    William F. Regine
    Mark V. Mishra
    Radiation Oncology, 15
  • [5] Immune checkpoint inhibition in patients with brain metastases
    Johanns, Tanner
    Waqar, Saiama N.
    Morgensztern, Daniel
    ANNALS OF TRANSLATIONAL MEDICINE, 2016, 4
  • [6] INTRACRANIAL OUTCOMES OF DUAL IMMUNE-CHECKPOINT INHIBITION AND SRS COMBINATION IN PATIENTS WITH MELANOMA AND NSCLC BRAIN METASTASES
    Vaios, Eugene
    Shenker, Rachel
    Hendrickson, Peter
    Wan, Zihan
    Niedzwiecki, Donna
    Winter, Sebastian F.
    Dietrich, Jorg
    Salama, April
    Clarke, Jeffrey
    Allen, Karen
    Mullikin, Trey
    Floyd, Scott
    Kirkpatrick, John
    Reitman, Zachary
    NEURO-ONCOLOGY, 2023, 25
  • [7] Risk of radionecrosis in brain metastases treated with SRT and systemic therapy
    Holub, K.
    Louvel, G.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S474 - S475
  • [8] Immune checkpoint inhibitors and stereotactic radiosurgery (SRS) in melanoma brain metastases
    Fenioux, Charlotte
    Troussier, Idriss
    Mazeron, Jean-Jacques
    Canova, Charles Henry
    Saiag, Philippe
    Fort, Magali
    Spano, Jean-Philippe
    Kourilsky, Antoine
    Lamproglou, Ioannis
    Maingon, Philippe
    Valery, Charles
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [9] Radionecrosis in patients with brain metastases treated with stereotactic radiotherapy.
    Fernandez Alonso, S.
    Guardado Gonzales, S. G.
    Pozo Rodriguez, G.
    Lora Pablos, D.
    Perez-Regadera Gomez, J. F.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S481 - S482
  • [10] MANAGEMENT OF RADIONECROSIS AFTER STEREOTACTIC RADIATION FOR BRAIN METASTASES IN THE SETTING OF IMMUNE CHECKPOINT INHIBITORS
    Jurica, James
    Bernicker, Eric
    Dalwadi, Shraddha
    Tremont-Lukats, Ivo
    Butler, Brian
    Teh, Bin
    Farach, Andrew
    NEURO-ONCOLOGY, 2018, 20 : 195 - 195
12345